Nuclera is a venture-backed, founder-driven biotech company headquartered in Cambridge, UK with significant operations in Boston, USA. The company’s mission is to improve human health by making proteins accessible. We are beginning this mission through the launch of our eProtein Discovery™ platform. eProtein Discovery is a breakthrough protein expression, characterization, and purification technology, consisting of a lab-based benchtop instrument, cloud-based software and proprietary cartridges and consumables. The goal is to enable rapid protein access to life science researchers around the world.
The successful candidate will be responsible for amplifying DNA constructs as well as delivering custom projects using our eProtein Discovery Platform in strict accordance with SOPs and work instructions. This position requires the ability to deliver under tight deadlines, attention to detail and strong organizational skills while working independently in a fast-paced environment. The ideal candidate will have a strong background in protein science, molecular biology, or a related discipline, with proven hands-on experience in an industry setting.
About the role
Requirements
Essential
Desirable
Benefits
What we offer: In addition to competitive salaries, we offer a range of benefits including:

Nuclera exists to remove uncertainty from protein science. As the pioneer of multiplex protein screening, we help researchers start with clarity, so ideas move faster to result. We believe access to your protein should be a certainty, not a gamble. eProtein Discovery™ is how we deliver on that promise, but our aim is bigger: to make protein access routine for every lab, accelerate breakthroughs in human health, and empower scientists to spend more time on discovery and less on delay.
Our eProtein Discovery™ system combines unique cell free expression systems, novel digital microfluidics, and robust screening data, to create an effortlessly multiplex protein screening solution that empowers you to perform your own protein screening, characterization, and small-scale expression in-house within days — even challenging membrane proteins
Founded in 2013 by PhD students at the University of Cambridge, the company now has a presence in Cambridge, UK and Boston, MA employing over 100 employees.